Dry Needling Versus Stretching for Muscle Extensibility

Not Applicable

Completed

• Conditions: Osteoarthritis, Hip
• Interventions: Other: Dry needling

• Registration Number: NCT04400825
• Lead Sponsor: Universidad de Zaragoza

Brief Summary

Hip osteoarthritis (OA) is one of the most prevalent chronic disease in the world. Currently several authors have shown the presence of active myofascial trigger points (MTrP) in the muscles surrounding the hip joint that reproduce the symptoms of the patients with hip OA.

Despite of the beneficial effects that have shown may conservative non-pharmacological treatments, there is a lack of studies evaluating the effects of the conservative treatments on muscle extensibility.

According to the new paradigm about the presence of MTrPs, the investigators decided to conduct a randomized clinical trial to compare the effects of DN intervention and stretching protocol on muscle extensibility in patients with hip OA.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-05-01
• Study First Submitted: 2020-05-19
• Study First Submitted QC: 2020-05-19
• Study First Posted: 2020-05-26
• Primary Completion: 2020-07-19
• Study Completion: 2020-07-19
• Status Verified: 2020-11
• Last Update Submitted: 2020-11-02
• Last Update Posted: 2020-11-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 38

Inclusion Criteria

• unilateral hip OA diagnosed medically with a X-Ray tess and following the American College of Rheumatology Criteria

Exclusion Criteria

• Secondary osteoarthritis by a traumatism, Paget disease, inflammatory or metabolic disease, congenital diseases etc.
• Vascular or neurological disease.
• Musculoskeletal pathologies in lumbar spine, pelvis or lower limbs
• DN contraindications or fear of needles

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Dry needling	Dry needling	Dry needling of 3 active MTrPs at most.
Stretching	Dry needling	Stretching of the main hip flexors (rectus femoris, iliopsoas and tensor fasciae latae)

Primary Outcome Measures

Name	Time	Method
muscle extensibility	up to 3 weeks	the examiners assess the muscle extensibility using an inclinomenter

Secondary Outcome Measures

Name	Time	Method
Stiffness	up to 3 weeks	the examiners assess the stiffness using the WOMAC stiffness subscale

Trial Locations

Locations (1)

Luis Ceballos Laita; 🇪🇸 Soria, Spain